| Dissecting the Role of MIcrobioMe in gastroEsophageal Tumor: a multIdisCiplinary Longitudinal Study (NCT06405035) | European Institute of Oncology | 2022-03-08 |
| (Concerto) Study of BLU-451 in Advanced Cancers With EGFR Exon 20 Insertion Mutations (NCT05241873) | Blueprint Medicines Corporation | 2022-03-04 |
| A Multicenter Clinical Trial of Sputum DNA Testing for Lung Cancer in China (NCT05337163) | Creative Biosciences (Guangzhou) Co., Ltd. | 2022-02-25 |
| Telemedicine in the Management of Pain in Patients With Advanced or Metastatic Pancreatic Cancer (NCT04667403) | Institut Cancerologie de l'Ouest | 2022-02-07 |
| (HARMONY) Study of BLU-701 in EGFR-mutant NSCLC (NCT05153408) | Blueprint Medicines Corporation | 2022-01-13 |
| Perioperative Chemoimmunotherapy With/Without Preoperative Chemoradiation for Locally Advanced Gastric Cancer (NCT05161572) | Fudan University | 2021-09-28 |
| (SYMPHONY) Phase 1/2 Study Targeting EGFR Resistance Mechanisms in NSCLC (NCT04862780) | Blueprint Medicines Corporation | 2021-06-29 |
| The Registry of Oncology Outcomes Associated With Testing and Treatment (NCT04028479) | Taproot Health | 2021-05-05 |
| CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors (NCT04660929) | Carisma Therapeutics Inc | 2021-02-02 |
| Novel SEQUEnced Immunotherapy With Anti-angiogenesis and Chemotherapy in Advanced gastroesophageaL Adenocarcinoma (NCT04069273) | Harry H Yoon | 2020-12-01 |
| A Study of JNJ-69086420, an Actinium-225-Labeled Antibody Targeting Human Kallikrein-2 (hK2) for Advanced Prostate Cancer (NCT04644770) | Janssen Research & Development, LLC | 2020-11-12 |
| Chemo4METPANC Combination Chemokine Inhibitor, Immunotherapy, and Chemotherapy in Pancreatic Adenocarcinoma (NCT04543071) | Gulam Manji | 2020-11-09 |
| Synergistic Effect of Elemene Plus TKIs Compared With TKIs in EGFR-mutated Advanced NSCLC：Prospective Study (NCT04401059) | Tian Xie | 2020-11-09 |
| Trial of Cabozantinib Plus Atezolizumab in Advanced and Progressive Neoplasms of the Endocrine System. The CABATEN Study (NCT04400474) | Grupo Espanol de Tumores Neuroendocrinos | 2020-10-07 |
| A Study of Pralsetinib Versus Standard of Care for First-Line Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC) (NCT04222972) | Hoffmann-La Roche | 2020-07-24 |
| Rigosertib Plus Nivolumab for KRAS+ NSCLC Patients Who Progressed on First-Line Treatment (NCT04263090) | Icahn School of Medicine at Mount Sinai | 2020-06-29 |
| Safety of Combining Irinotecan With 5-FU, Leucovorin/Folinic Acid, Oxaliplatin, and Docetaxel Chemotherapies (NCT04361708) | University of Chicago | 2020-05-08 |
| SERum-bank for PANcreatic Cancer (NCT04374175) | Centre Hospitalier Universitaire de Saint Etienne | 2020-04-01 |
| Study of High Dose Intravenous (IV) Ascorbic Acid in Measurable Solid Tumor Disease (NCT01125449) | Situs Cancer Research Center | 2020-01-01 |
| Study on Predictive Biomarkers of Neoadjuvant Chemoradiotherapy for Rectal Cancer (NCT04227886) | Fudan University | 2019-12-01 |
| Abemaciclib and Pembrolizumab in Locally Advanced Unresectable or Metastatic Gastroesophageal Adenocarcinoma: Big Ten Cancer Research Consortium BTCRC-GI18-149 (NCT03997448) | Nataliya Uboha | 2019-08-26 |
| A Study Evaluating Safety and Efficacy of Niraparib in Patients With Previously Treated Metastatic Esophageal/Gastroesophageal Junction/Proximal Gastric Adenocarcinoma (NCT03840967) | Shadia Jalal, MD | 2019-07-09 |
| A Phase 2 Trial of High-dose Ascorbate for Pancreatic Cancer (PACMAN 2.1) (NCT02905578) | University of Iowa | 2018-11-28 |
| Study of Anlotinib Plus Chemotherapy as the First-line Treatment in Patients With Advanced NSCLC (NCT03636685) | Chinese Academy of Medical Sciences | 2018-08-15 |
| A Study of Anlotinib in Recurrent/Metastatic Head and Neck Adenocarcinomas (NCT03591666) | Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University | 2018-07-15 |
| Perioperative mFOLFOX Plus Pembrolizumab in Gastroesophageal Junction (GEJ) and Stomach Adenocarcinoma (NCT03488667) | University of Kansas Medical Center | 2018-06-27 |
| A Study of Gemcitabine, Nab-paclitaxel, Capecitabine, Cisplatin, and Irinotecan in Metastatic Pancreatic Cancer (NCT03535727) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2018-06-21 |
| A Data Collection Study for Patients With Adenocarcinoma Treated With the MyVaccx Immunotherapy Regimen. (NCT03695835) | Gary Onik MD | 2018-04-11 |
| Paclitaxel Protein Bound Plus Cisplatin Plus Gemcitabine and Paricalcitol for Pancreatic Adenocarcinoma (NABPLAGEMD) (NCT03415854) | HonorHealth Research Institute | 2018-01-31 |
| PRIMER: Development of Daily Online Magnetic Resonance Imaging for Magnetic Resonance Image Guided Radiotherapy (NCT02973828) | Institute of Cancer Research, United Kingdom | 2017-10-17 |
| A Study of IMU-131(HER-Vaxx) and Chemotherapy Compared to Chemotherapy Only in Patients With HER2 Positive Advanced Gastric Cancer (NCT02795988) | Imugene Limited | 2017-08-30 |
| Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors (NCT03037385) | Hoffmann-La Roche | 2017-03-17 |
| Safety and Efficacy of Avelumab in Small Intestinal Adenocarcinoma (NCT03000179) | Vanderbilt-Ingram Cancer Center | 2017-03-03 |
| Next Generation Sequencing of Tumor Cells in Locally Advanced Pancreatic Adenocarcinoma (NCT03578939) | Istituto Clinico Humanitas | 2017-01-01 |
| A Study of Perioperative mFOLFOX6 Plus Pembrolizumab in Patients With Potentially Resectable Adenocarcinoma of the Gastroesophageal Junction (GEJ) and Stomach (NCT02943603) | Weijing Sun, MD, FACP | 2017-01-01 |
| Isolating and Testing Circulating Tumor DNA and Soluble Immune Markers During the Course of Treatment for Lung Cancer (NCT02410603) | Mayo Clinic | 2016-12-01 |
| cSMART Liquid Biopsy and Dynamic Monitor of NSCLC Patients in Inner-Mongolia China (NCT02980536) | Berry Genomics Co., Ltd. | 2016-11-01 |
| CTC Pancreatic Adenocarcinoma (NCT02335151) | University of Zurich | 2016-10-01 |
| Phase I/II Study of CK-101 in NSCLC Patients and Other Advanced Solid Tumors (NCT02926768) | Checkpoint Therapeutics, Inc. | 2016-09-01 |
| Personalised Therapy for Metastatic ADPC Determined by Genetic Testing and Avatar Model Generation (NCT02795650) | Hospital Universitario de Fuenlabrada | 2016-05-01 |
| A Study of GSK2256098 and Trametinib in Advanced Pancreatic Cancer (NCT02428270) | University Health Network, Toronto | 2016-04-01 |
| LRP1 and Colon Cancer (NCT02788669) | CHU de Reims | 2015-11-01 |
| Metformin Plus Irinotecan for Refractory Colorectal Cancer (NCT01930864) | Barretos Cancer Hospital | 2015-09-01 |
| Efficacy and Safety of Adjuvant Pemetrexed Plus Cisplatin for Adenocarcinoma of Lung (NCT02498860) | Chonnam National University Hospital | 2015-09-01 |
| Eribulin as 1st Line Treatment in Elderly Patients With Advanced Breast Cancer (NCT02404506) | Swiss Cancer Institute | 2015-08-17 |
| PEGPH20, Gemicitabine and Nab-Paclitaxel for Pancreatic Ductal Adenocarcinoma (NCT02487277) | Andrew Ko | 2015-07-14 |
| Neoadjuvant Metformin in Association to Chemoradiotherapy for Locally Advanced Rectal Cancer (NCT02473094) | University of Campinas, Brazil | 2015-07-01 |
| The Potential for Metformin to Improve Tumor Oxygenation in Locally Advanced Cervix Cancer: A Phase II Randomized Trial (NCT02394652) | University Health Network, Toronto | 2015-05-21 |
| National Lung Matrix Trial: Multi-drug Phase II Trial in Non-Small Cell Lung Cancer (NCT02664935) | University of Birmingham | 2015-05-13 |
| Esophagectomy for Patients With Esophageal Cancer and Cervical Lymph Node Metastases (NCT02426879) | UMC Utrecht | 2015-02-11 |
| A Study of MM-121 in Combination With Chemotherapy Versus Chemotherapy Alone in Heregulin Positive NSCLC (NCT02387216) | Elevation Oncology | 2015-02-01 |
| PANGEA-IMBBP: Personalized Antibodies for Gastro-Esophageal Adenocarcinoma - A 1st Pilot Metastatic Trial of Biologics Beyond Progression (NCT02213289) | University of Chicago | 2015-01-20 |
| Minimally Invasive Sweet Esophagectomy for Patients With Siewert Type II Adenocarcinoma of the Esophagogastric Junction (NCT02741778) | Anhui Provincial Hospital | 2015-01-01 |
| Pilot Study of Short-Course Preoperative Stereotactic Body Radiation Therapy for Resectable Pancreatic Cancer (NCT02347618) | University of Rochester | 2014-12-01 |
| T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer (NCT02133196) | National Cancer Institute (NCI) | 2014-10-23 |
| Beyond TME Origins (NCT02292641) | Imperial College London | 2014-09-25 |
| Knowledge, Attitudes, and Practice of Surgeons Toward Nutrition Support in HIPEC Patients (NCT02374411) | Edward Hospital | 2014-09-01 |
| Icotinib Versus Placebo as Adjuvant Therapy in EGFR-mutant Lung Adenocarcinoma (NCT02125240) | Betta Pharmaceuticals Co., Ltd. | 2014-09-01 |
| A Study to Isolate and Test Circulating Tumor Cells Using the ClearCell® FX EP+ System (NCT02370303) | Mayo Clinic | 2014-08-01 |
| Cancer-related Thromboembolic Disease (NCT02785757) | Hospices Civils de Lyon | 2014-07-12 |
| Sequential and Maintenance Icotinib Plus Chemotherapy Versus Icotinib Maintenance After Chemotherapy in Advanced NSCLC (NCT02194556) | Betta Pharmaceuticals Co., Ltd. | 2014-07-01 |
| Safety and Efficacy Study of Abraxane in Combination With Carboplatin to Treat Advanced NSCL Cancer in the Elderly (NCT02151149) | Celgene | 2014-06-09 |
| Preoperative Chemoradiation Followed by Chemotherapy for Locally Advanced Rectal Cancer (NCT01952951) | National Cancer Center, Korea | 2014-06-01 |
| EUCROSS: European Trial on Crizotinib in ROS1 Translocated Lung Cancer (NCT02183870) | University of Cologne | 2014-05-01 |
| Sequential Icotinib Plus Chemotherapy Versus Icotinib Alone as First-line Treatment in Stage IIIB/IV Lung Adenocarcinoma (NCT02103257) | Betta Pharmaceuticals Co., Ltd. | 2014-03-01 |
| Dose-Guided Radiotherapy in Oesophageal Cancer: Managing the Real Dose (NCT02130011) | Maastricht Radiation Oncology | 2014-03-01 |
| HIPEC For Peritoneal Surface Malignancies Including Carcinomatosis or Sarcomatosis - Data Registry (NCT02082886) | Edward-Elmhurst Health System | 2014-02-01 |
| Treatment of Multifocal Lung Adenocarcinoma (NCT01946100) | Mayo Clinic | 2013-11-06 |
| Induction Chemotherapy, Chemoradiotherapy and Surgery in Locally Advanced Gastric Cancer Patients (NCT02454647) | Clinica Universidad de Navarra, Universidad de Navarra | 2013-09-01 |
| A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ-42756493 in Patients With Advanced or Refractory Solid Tumors or Lymphoma (NCT01962532) | Janssen Research & Development, LLC | 2013-08-21 |
| Dose Escalation Study MORAb-066 Targeting Tissue Factor (TF)-Expressing Malignancies Including Breast, Pancreatic, Colorectal, NSCLC (NCT01761240) | Morphotek | 2013-06-19 |
| Molecular, Pathologic and MRI Investigation of the Prognostic and Redictive Importance of Extramural Venous Invasion in Rectal Cancer (MARVEL) Trial (NCT01995942) | Royal Marsden NHS Foundation Trust | 2013-06-07 |
| Combining MLN8237 With Nab-Paclitaxel in Patients With Advanced Solid Malignancies (NCT01677559) | Washington University School of Medicine | 2013-05-07 |
| VEGFR/PDGFR Dual Kinase Inhibitor X-82 and Everolimus for Treating Patients With Pancreatic Neuroendocrine Tumors (NCT01784861) | Washington University School of Medicine | 2013-05-03 |
| Icotinib as First-line and Maintenance Treatment in EGFR Mutated Patients With Lung Adenocarcinoma (NCT01665417) | Betta Pharmaceuticals Co., Ltd. | 2012-08-01 |
| MRI Guided High Intensity Focused Ultrasound (HIFU) and ThermoDox for Palliation of Painful Bone Metastases (NCT01640847) | Imunon | 2012-07-01 |
| Pilot and Feasibility Study of the Imaging Potential of EC17: Intraoperative Folate-fluorescein Conjugate (EC17) Lung Cancer (CA) (NCT01778920) | University of Pennsylvania | 2012-04-01 |
| Combination Immunotherapy of GM.CD40L Vaccine With CCL21 in Lung Cancer (NCT01433172) | H. Lee Moffitt Cancer Center and Research Institute | 2012-03-26 |
| Signet Ring Cell Carcinoma in Esophageal Adenocarcinoma (NCT01824966) | University Hospital, Gasthuisberg | 2012-03-01 |
| Intercalated Administration of PamCis With Gefitinib or Placebo as First Line Lung Adenocarcinoma in Never Smokers (NCT01502202) | National Cancer Center, Korea | 2012-03-01 |
| Cancer Vaccine Targeting Brachyury Protein in Tumors (NCT01519817) | National Cancer Institute (NCI) | 2012-01-05 |
| Slide Interpretation or Standard Surgical Pathology in Assessing Margin Status in Patients With Pancreatic Cancer Undergoing Surgery (NCT01646697) | Ohio State University Comprehensive Cancer Center | 2011-11-07 |
| Prospective Randomized Study of SILS Versus CLS for Rectal Cancer (NCT01579721) | Hvidovre University Hospital | 2011-09-01 |
| FOLFIRINOX Plus IPI-926 for Advanced Pancreatic Adenocarcinoma (NCT01383538) | Andrew Ko | 2011-08-23 |
| Extraperitoneal Para-aortic Lymph Node Dissection (EPLND) for Cervix (NCT01365156) | M.D. Anderson Cancer Center | 2011-08-01 |
| Prospective Randomized Trial Comparing Robotic Versus Open Radical Prostatectomy (NCT01365143) | Mayo Clinic | 2011-05-01 |
| Taxotere®, Eloxatin® and Xeloda® (TEX) in Combination With Herceptin® as Treatment for HER2 Positive Non-resectable Cancer (NCT01295086) | Odense University Hospital | 2011-03-01 |
| Study of Nimotuzumab, Radiation Therapy and Cisplatin Versus Radiation Therapy and Cisplatin for Treatment of Stage IB e IVA UCC(CORUS) (NCT01301612) | Eurofarma Laboratorios S.A. | 2011-01-01 |
| AXP107-11 in Combination With Standard Gemcitabine (Gemzar® ) Therapy for Treatment in Patients With Pancreatic Cancer (NCT01182246) | Axcentua Pharmaceuticals AB | 2010-11-01 |
| Study of Weekly Paclitaxel With Ramucirumab in Participants With Advanced Gastric Adenocarcinomas (NCT01253525) | Eli Lilly and Company | 2010-11-01 |
| Assessment of Response Before, During and After Neoadjuvant Chemoradiotherapy in Rectal Cancer Patients (NCT01171300) | Universitaire Ziekenhuizen KU Leuven | 2010-10-01 |
| School Response to Families Who Have Children With Cancer (NCT01148082) | Stanford University | 2010-09-01 |
| FOLFOX/Bevacizumab/Hydroxychloroquine (HCQ) in Colorectal Cancer (NCT01206530) | Abramson Cancer Center at Penn Medicine | 2010-09-01 |
| SBRT for Organ Confined Prostate Cancer (NCT02653248) | Northwell Health | 2010-08-01 |
| Nab-paclitaxel (Abraxane), Gemcitabine, and Capecitabine (Xeloda) for Pancreatic Adenocarcinoma (NCT01161186) | University of California, San Francisco | 2010-07-01 |
| BIBW 2992 (Afatinib) vs Gemcitabine-cisplatin in 1st Line Non-small Cell Lung Cancer (NSCLC) (NCT01121393) | Boehringer Ingelheim | 2010-04-19 |
| Impact of Positron Emission Tomography (PET) Imaging in Women With Locally Advanced Cervical Cancer (PET LACE Trial) (NCT00895349) | Ontario Clinical Oncology Group (OCOG) | 2010-04-01 |
| Observational Study of Incidence Rates of Esophageal Cancer in Women Taking Medications for the Prevention or Treatment of Osteoporosis (MK-0217A-352) (NCT01077817) | Organon and Co | 2010-02-26 |
| CLE for Assessment of Neoplasia After Mucosal Ablation or Resection of Gastrointestinal Neoplasia (NCT01032044) | Mauna Kea Technologies | 2010-02-01 |
| Efficacy and Tolerability of ABT-869 Versus Sorafenib in Advanced Hepatocellular Carcinoma (HCC) (NCT01009593) | Abbott | 2010-01-01 |